New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 2, 2020 - Macoven launched an authorized brand alternative of Currax’s Silenor (doxepin) tablets
Download PDF
Return to publications
